Ephedrine pharmacokinetics after the ingestion of nutritional supplements containing Ephedra sinica (ma huang)

被引:55
作者
Gurley, BJ
Gardner, SF
White, TM
Wang, PL
机构
[1] Univ Arkansas Med Sci, Coll Pharm, Dept Pharmaceut, Little Rock, AR 72205 USA
[2] Univ Arkansas Med Sci, Coll Pharm, Dept Pharm Practice, Little Rock, AR 72205 USA
关键词
ephedrine; Ephedra sinica; ma huang; pharmacokinetics;
D O I
10.1097/00007691-199808000-00015
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Nutritional supplements containing Ephedra sinica (ma huang), a botanical source of ephedrine alkaloids, have been linked to several episodes of ephedrine toxicity and at least 17 deaths, yet these products remain unregulated. Ten subjects were enrolled in a randomized, crossover study aimed at characterizing the pharmacokinetics of ephedrine after the ingestion of three commercially available ma huang products compared with a 25-mg ephedrine capsule. Pharmacokinetic parameters for botanical ephedrine were similar to those for synthetic ephedrine hydrochloride. Gender-based comparisons of V-ss/F and CL/F revealed higher values for women than for men (V-ss/F, 3.49 +/- 1.04 vs 2.98 +/- 0.73 l/kg; CL/F, 0.48 +/- 0.11 vs 0.37 +/- 0.11 l/hour.kg). The current study suggests that the increased incidence of ma huang toxicity does not stem from differences in the absorption of botanical ephedrine compared with synthetic ephedrine; rather, it results from accidental overdose often prompted by exaggerated off-label claims and a belief that "natural" medicinal agents are inherently safe.
引用
收藏
页码:439 / 445
页数:7
相关论文
共 29 条
[1]   FDA proposes limits on ephedrine supplements [J].
Ault, A .
LANCET, 1997, 349 (9067) :1753-1753
[2]  
Betz JM, 1997, J AOAC INT, V80, P303
[3]   SENSITIVE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF PSEUDOEPHEDRINE IN PLASMA AND URINE [J].
BRENDEL, E ;
MEINEKE, I ;
HENNE, EM ;
ZSCHUNKE, M ;
DEMEY, C .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1988, 426 (02) :406-411
[4]   A PHARMACODYNAMIC INTERACTION BETWEEN CAFFEINE AND PHENYLPROPANOLAMINE [J].
BROWN, NJ ;
RYDER, D ;
BRANCH, RA .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1991, 50 (04) :363-371
[5]  
Doyle H, 1996, BRIT MED J, V313, P756
[6]  
Gurley Bill J., 1997, Pharmaceutical Research (New York), V14, pS582
[7]   Herbal stimulant causes US deaths [J].
Josefson, D .
BRITISH MEDICAL JOURNAL, 1996, 312 (7043) :1378-1379
[8]  
KANFER I, 1993, PHARMACOTHERAPY, V13, pS116
[9]   AN INTERACTIVE PROGRAM FOR PHARMACOKINETIC MODELING [J].
LU, DR ;
MAO, FW .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1993, 82 (05) :537-542
[10]   GROWING USE OF MEDICINAL BOTANICALS FORCES ASSESSMENT BY DRUG REGULATORS [J].
MARWICK, C .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (08) :607-609